Retroviral intasome assembly and inhibition of DNA strand transfer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The structures revealed unexpected architectural diversity among intasomes from different retroviral genera.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with their function, all intasomes feature 2-fold symmetry and harbour a pair of juxtaposed active sites engaged with 3’ vDNA ends.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Within the CIC, the IN dimers are bridged via the exchange of associated NTDs and are joined by a pair of CTDs (referred to as the synaptic CTDs), which act as rigid spacers.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the intasomes from the prototype foamy virus (PFV, a simiispumavirus) as well as the δ-retroviruses HTLV-1 and simian T-cell lymphotropic virus (STLV) contain four IN subunits (arranged as a dimer-of-dimers)25,29,37,38”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these differences, all intasomes incorporate the conserved intasome core (CIC) assembly, which is the minimal functional unit and is represented by the PFV structure (Figs. 2A, 3).”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
The Buccaneer software for automated model building. 1. Tracing protein chains
Cowtan, K. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906022116 · Cited by 1,822
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
Gouet, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg556 · Cited by 1,509
Research works printed but not linked: 2
- Grobler, J. A., Stillmock, K., Miller, M. D. & Hazuda, D. J. Mechanism by which the HIV integrase active-site mutation N155H confers resistance to raltegravir. Antivir. Ther. 13 (suppl. 3). A41 (2008)
- Leslie, A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF-EAMCB Newsletter on Protein Crystallography no. 26, (1992)
Cited by
Items 401–500 of 719
Engelman, A., & Cherepanov, P. (2020) · FEBS Journal · doi:10.1111/febs.15438 · Cited by 12
Self-citationXue, W., Zhu, F., Yang, F., Yang, J., Zhang, Z., Tu, G., & Yao, X. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210708090123 · Cited by 11
“Chen et al. [37] constructed a series of HIV-1 IN homology models using the crystal structure of the full length PFV (PDB code: 3L2U) and HIV-1 integrase sequence [38].”
MethodInsight into the molecular mechanism of the transposon-encoded type I-F CRISPR-Cas system
Alalmaie, A., Diaf, S. R., & Khashan, R. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00507-8 · Cited by 12
Pharmacophore-based database mining for probing fragmental drug-likeness of diketo acid analogues
Bąk, A., Magdziarz, T., & Polański, J. (2012) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2011.645875 · Cited by 11
“Comprehensive understanding of the INSTI binding mode has been hampered by the lack of a full-length experimental structure of retroviral IN, either separately or in a stable synaptic complex with DNA, namely the functional intasome [33].”
BackgroundReduced HIV-1 integrase flexibility as a mechanism for raltegravir resistance
Dewdney, T. G., Wang, Y., Kovari, I. A., Reiter, S. J., & Kovari, L. C. (2013) · Journal of Structural Biology · doi:10.1016/j.jsb.2013.07.008 · Cited by 16
HIV-1 Integrase Strand Transfer Inhibitors Stabilize an Integrase–Single Blunt-Ended DNA Complex
Bera, S., Pandey, K. K., Vora, A. C., & Grandgenett, D. P. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.043 · Cited by 13
Rostami, M. R., Sirous, H., Zabihollahi, R., Aghasadeghi, M. R., Sadat, S. M., Namazi, R., Saghaie, L., Memarian, H. R., & Fassihi, A. (2015) · Medicinal Chemistry Research · doi:10.1007/s00044-015-1443-4 · Cited by 12
“(Hare et al., 2010).”
Billamboz, M., Suchaud, V., Bailly, F., Lion, C. J., Andréola, M., Christ, F., Debyser, Z., & Cotelle, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.083 · Cited by 11
Removal of nuclease contamination during purification of recombinant prototype foamy virus integrase
Lopez, M. A., Mackler, R. M., & Yoder, K. E. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.06.002 · Cited by 11
Guan, R., Aiyer, S., Coté, M. L., Xiao, R., Jiang, M., Acton, T., Roth, M. J., & Montelione, G. T. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25245 · Cited by 13
Influence of the amino-terminal sequence on the structure and function of HIV integrase
Eilers, G., Gupta, K., Allen, A., Zhou, J. O., Hwang, Y., Cory, M., Bushman, F. D., & Duyne, G. D. V. (2020) · Retrovirology · doi:10.1186/s12977-020-00537-x · Cited by 11
Aires‐da‐Silva, F., Li, M., Rato, S., Maia, S., Malhó, R., Warren, K., Harrich, D., Craigie, R., Barbas, C. F., & Gonçalves, J. (2012) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1034 · Cited by 13
HIV Virions as Nanoscopic Test Tubes for Probing Oligomerization of the Integrase Enzyme
Borrenberghs, D., Thys, W., Rocha, S., Demeulemeester, J., Weydert, C., Dedecker, P., Hofkens, J., Debyser, Z., & Hendrix, J. (2014) · ACS Nano · doi:10.1021/nn406615v · Cited by 13
IS21 family transposase cleaved donor complex traps two right-handed superhelical crossings
Spínola‐Amilibia, M., Araújo‐Bazán, L., de la Gándara, Á., Berger, J. M., & Arias‐Palomo, E. (2023) · Nature Communications · doi:10.1038/s41467-023-38071-x · Cited by 20
“7) 54,57,59 – 61 .”
Sangeetha, B., Muthukumaran, R., & Ramaswamy, A. (2013) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2013.792870 · Cited by 9
“The crystal structure of PFV integrase bound with two Mn ions (PDB ID: 3OY9) was used as template [30,31] and the generated model was minimized using MacroModel in an implicit solvent environment.”
MethodDNA requirements for assembly and stability of HIV‐1 intasomes
Li, M., Ivanov, V., Mizuuchi, M., Mizuuchi, K., & Craigie, R. (2011) · Protein Science · doi:10.1002/pro.2010 · Cited by 10
Integrase inhibitors: current protagonists in antiretroviral therapy
Loaiza, J. D., Chvatal‐Medina, M., Hernández, J. C., & Rugeles, M. T. (2023) · Immunotherapy · doi:10.2217/imt-2023-0011 · Cited by 11
Nakamura, T., Okumura, M., Takamune, N., Hirotsu, T., Sugiura, M., Yasunaga, J., & Nakata, H. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad446 · Cited by 9
“To analyze the interaction of H-RAL with HIV-IN, we performed a docking simulation using crystallography (PDB accession numbers 3L2V, 3OYA, and 7OUG) (32 – 34).”
MethodUnprocessed Viral DNA Could Be the Primary Target of the HIV-1 Integrase Inhibitor Raltegravir
Ammar, F. F., Abdel‐Azeim, S., Zargarian, L., Hobaika, Z., Maroun, R. G., & Fermandjian, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040223 · Cited by 11
“Bujalwski and Lohman procedure [40], showed that a single RAL molecule was bound to LTR32 (1:1 stoichiometry), in agreement with the crystal structure results [15].”
BackgroundResultInfluentialStrain-specific effect on biphasic DNA binding by HIV-1 integrase
Hill, K. J., Rogers, L. C., Njenda, D. T., Burke, D. H., Sarafianos, S. G., Sönnerborg, A. B., Neogi, U., & Singh, K. (2018) · AIDS · doi:10.1097/qad.0000000000002078 · Cited by 10
“This result is not surprising, as no coordination of Mg2þ with DNA (Protein Data Bank file 3L2R [12]) was noted in preintegration prototype foamy virus (PFV) integrase/ DNA complex.”
Ethyl malonate amides: A diketo acid offspring fragment for HIV integrase inhibition
Serafin, K., Mazur, P., Bąk, A., Laine, É., Tchertanov, L., Mouscadet, J. F., & Polański, J. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.054 · Cited by 9
Raltegravir in HIV-1 Infection: Safety and Efficacy in Treatment-Naïve Patients
Pandey, K. K. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s5022 · Cited by 14
Pandey, K. K., Bera, S., Korolev, S., Campbell, M. A., Yin, Z., Aihara, H., & Grandgenett, D. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573311 · Cited by 9
“In addition, the linkers between the N-terminal and catalytic core domains and in particular between the catalytic core and C-terminal domains are significantly longer in the distantly related four-domain PFV IN (6, 7) than the corresponding linkers in RSV or HIV IN.”
BackgroundInfluentialGérard, A., Soler, N., Ségéral, E., Belshan, M., & Emiliani, S. (2013) · Retrovirology · doi:10.1186/1742-4690-10-13 · Cited by 12
“Indeed, the functional intasome is formed by tetramer of IN tightly bound to the LTR ends of the newly synthesized viral cDNA [82,83].”
BackgroundAssembly and Purification of Prototype Foamy Virus Intasomes
Mackler, R. M., Lopez, M. A., & Yoder, K. E. (2018) · Journal of Visualized Experiments · doi:10.3791/57453 · Cited by 11
Peese, K. M., Naidu, B. N., Patel, M., Li, C., Langley, D. R., Terry, B., Protack, T., Gali, V., Lin, Z., Samanta, H. K., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126784 · Cited by 10
A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor
Nakamura, T., Nakamura, T., Amano, M., Miyakawa, T., Yamagata, Y., Matsuoka, M., & Nakata, H. (2020) · Journal of Virology · doi:10.1128/jvi.00486-20 · Cited by 9
Luo, Z., Zhao, Y. C., Ma, C., Li, Z., Xu, X., Hu, L., Huang, N., & He, H.-Q. (2015) · Archiv der Pharmazie · doi:10.1002/ardp.201400390 · Cited by 9
Hu, J., Liu, M., Tang, D., & Chang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054929 · Cited by 9
“PFV IN has highly structural and functional homology with HIV-1 IN [18].”
BackgroundPeletskaya, E. N., Andrake, M., Gustchina, A., Merkel, G. W., Alexandratos, J. N., Zhou, D., Bojja, R. S., Satoh, T., Potapov, M., Kogon, A. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027751 · Cited by 9
“Several models of IN-DNA complexes have been developed, originally based on other transposase-DNA structures [10,11], and more recently on the structures of PFV IN [7,12], but the conformational variability of integrase, particularly within the inter-domain linkers, exacerbated by the significant differences in their…”
BackgroundBera, S., Pandey, K. K., Aihara, H., & Grandgenett, D. P. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004768 · Cited by 7
“The composition of RSV STC containing IN octamers (2) is in contrast to the STC of the prototype foamy virus (PFV) that contains only an IN tetramer (1, 8, 9).”
The Unique, the Known, and the Unknown of Spumaretrovirus Assembly
Lindemann, D., Hütter, S., Wei, G., & Löchelt, M. (2021) · Viruses · doi:10.3390/v13010105 · Cited by 11
“Some unique or deviant sequence features of Pol proteins, for instance the unusual catalytic center of PR or the comparative ease of obtaining integrase (IN) crystals and thus the first authentic structural insights into RV/retroid element IN structure and function [20,36] may be consequences of the unique Pol express…”
BackgroundCellier, C., Moreau, K., Gallay, K., Ballandras-Colas, A., Gouet, P., & Ronfort, C. (2013) · Virology · doi:10.1016/j.virol.2013.02.001 · Cited by 10
“…recently, the first crystal structure of an entire retroviral IN, that of the prototype foamy virus (PFV) IN complexed with the double-strand vDNA, was determined at 2.9 Å resolution (Hare et al., 2010) and was used as a template to build a 3D model of the HIV-1 intasome (Krishnan et al., 2010).”
MethodInfluentialGalilee, M., & Alian, A. (2014) · Structure · doi:10.1016/j.str.2014.08.001 · Cited by 9
“…oligomeric states, including monomers and dimers, do exist in solution and the correct precursors in the tetramer assembly pathway are yet to be determined (Alian et al., 2009; Bojja et al., 2013; Hare et al., 2010; Lesbats et al., 2008; Li et al., 2006; Maertens et al., 2010; Pandey et al., 2011).”
BackgroundMethodInfluentialDrug resistant integrase mutants cause aberrant HIV integrations
Varadarajan, J., McWilliams, M. J., Mott, B. T., Thomas, C. J., Smith, S. J., & Hughes, S. H. (2016) · Retrovirology · doi:10.1186/s12977-016-0305-6 · Cited by 12
“Upon binding, INSTIs displace the dA at the very 3′ ends of viral DNA and have a π-stacking interaction with the penultimate nucleotide (dC) at both of the 3′ ends of the viral DNA [7–9].”
BackgroundInfluentialSun, Y., Xu, W., Fan, N., Sun, X., Ning, X., Ma, L., Liu, J., & Wang, X. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.035 · Cited by 9
Pandey, K. K., Bera, S., Shi, K., Aihara, H., & Grandgenett, D. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773382 · Cited by 8
“PFV IN is capable of directly producing a soluble tetrameric intasome without first producing insoluble IN-DNA complexes (5, 7, 8).”
BackgroundMethodInfluentialGallay, K., Blot, G., Chahpazoff, M., Yajjou, H., Confort, M.-P., de Boisséson, C., Roux, A. L., Luengo, C., Fiorini, F., Lavigne, M., et al. (2019) · Virology · doi:10.1016/j.virol.2019.04.002 · Cited by 10
Park, J.-H., Yun, J.-H., Shi, Y., Han, J., Li, X., Jin, Z., Kim, T., Park, J., Park, S., Liu, H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081943 · Cited by 11
Pala, N., Esposito, F., Tramontano, E., Singh, P. K., Sanna, V., Carcelli, M., Haigh, L. D., Satta, S., & Sechi, M. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00009 · Cited by 9
Depatureaux, A., Quashie, P. K., Mésplède, T., Han, Y.-S., Koubi, H., Plantier, J., Oliveira, M., Moisi, D. D., BRENNER, B. G., & Wainberg, M. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03819-14 · Cited by 11
“Molecular modeling was performed in silico: briefly, the structures of HIV-O integrases were generated by homology with the structure of the integrase from the prototype foamy virus (PFV) in complex with target DNA, as previously reported (18, 40), using an I-TASSER three-dimensional (3D) protein prediction server (41…”
BackgroundMethodHikichi, Y., Burdick, R. C., Patro, S. C., Ding, S.-Y., Luke, B. T., Clark, E., Ablan, S. D., Wu, X., Pathak, V. K., & Freed, E. O. (2025) · Science Advances · doi:10.1126/sciadv.adz8980 · Cited by 12
“As their name implies, INSTIs block the strand transfer activity of IN by binding the intasome rather than free IN ( 5 – 8 ).”
A new functional role of HIV-1 integrase during uncoating of the viral core
Briones, M. S., & Chow, S. A. (2010) · Immunologic Research · doi:10.1007/s12026-010-8164-z · Cited by 12
Development of a receptor model for efficient in silico screening of HIV-1 integrase inhibitors
Quevedo, M. A., Ribone, S. R., Briñón, M. C., & Dehaen, W. (2014) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2014.06.007 · Cited by 9
Fueling HIV-1 integrase drug design with structural insights
Demeulemeester, J., Christ, F., Maeyer, M. D., & Debyser, Z. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.05.005 · Cited by 9
Ko, G. M., Reddy, A. S., Kumar, S., Garg, R., Bailey, B., & Hadaegh, A. R. (2012) · IEEE Congress on Evolutionary Computation (CEC) · doi:10.1109/cec.2012.6256578 · Cited by 8
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
Pandey, K. K. (2014) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s39178 · Cited by 9
“64 These mutations diminish viral replication fitness and catalytic activities of recombinant IN. 17,59,60,65–68 Clinical trials with EVG in HIV-1-infected individuals have corroborated the in vitro findings.”
InfluentialStructural dynamics of full-length retroviral integrase: a molecular dynamics analysis
Balasubramanian, S., Rajagopalan, M., & Ramaswamy, A. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2011.672630 · Cited by 8
“Recently, Hare, Gupta, Valkov, Engelman, and Cherepanov ( 2010 ) set a remarkable milestone in the knowledge of IN and its function by solving a structure of retroviral intasome of prototype foamy virus (PFV) in which the tetrameric IN is complexed with DNA.”
BackgroundSafakish, M., Hajimahdi, Z., Vahabpour, R., Zabihollahi, R., & Zarghi, A. (2019) · Medicinal Chemistry · doi:10.2174/1573406415666190826161123 · Cited by 8
Abdollahi, O., Mahboubi, A., Hajimahdi, Z., & Zarghi, A. (2022) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-126562 · Cited by 8
Kumar, N., & Acharya, V. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106525 · Cited by 8
Zhao, X. Z., Métifiot, M., Smith, S. J., Maddali, K., Marchand, C., Hughes, S. H., Pommier, Y. G., & Burke, T. R. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150813150058 · Cited by 8
“Integrase strand transfer inhibitors (INSTIs) represent a new class of antiretroviral agents developed for the treatment of HIV-1 infections.”
BackgroundInfluentialSirous, H., Zabihollahi, R., Aghasadeghi, M. R., Sadat, S. M., Saghaie, L., & Fassihi, A. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1289-1 · Cited by 10
“(Hare et al., 2010).”
Azzi, S., Parissi, V., Maroun, R. G., Eid, P., Mauffret, O., & Fermandjian, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0016001 · Cited by 8
“The three domains taken separately or coupled in two-domain fragments (CCD-CTD and NTD-CCD) form a dimer [20], although the tetramer emerges as the functional association [21,22,23,24,25].”
BackgroundMethodInfluentialHIV-1 Integrase Drug Discovery Comes of Age
Demeulemeester, J., Maeyer, M. D., & Debyser, Z. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_33 · Cited by 9
Mariner and the ITm Superfamily of Transposons
Tellier, M., Bouuaert, C. C., & Chalmers, R. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch34 · Cited by 9
Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity
Guo, D., Zhang, X., Wang, R., Zhou, Y., Li, Z., Xu, J., Chen, K., Zheng, Y., & Liu, H. S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.070 · Cited by 8
Prospective Strategies for Targeting HIV-1 Integrase Function
Luo, Y., & Muesing, M. A. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.205 · Cited by 9
“In effect, the reactive 3′-hydroxyl groups (CAOH-3′) left at the vDNA ends by prior 3′-processing are selectively displaced by inhibitor binding, disarming any further reactivity of the complex [15,17].”
BackgroundJing, T., Shan, Z., Dinh, T., Biswas, A., Jang, S., Greenwood, J., Li, M., Zhang, Z., Gray, G., Shin, H. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64479-8 · Cited by 17
“Intasomes can be assembled in vitro from puri fi ed IN and vDNA oligonucleotides 6,7 .”
InfluentialSelf-citationHerzig, E., Voronin, N., & Hizi, A. (2012) · Journal of Virology · doi:10.1128/jvi.00009-12 · Cited by 7
“Only recently, the crystal structure of the full-length IN from the prototype foamy virus in complex with its cognate DNA was resolved (12).”
BackgroundEleventh International Foamy Virus Conference—Meeting Report
Buseyne, F., Antoine Gessain, A., Soares, M. A., Santos, A. F., Materniak-Kornas, M., Lesage, P., Zamborlini, A., Löchelt, M., Qiao, W., Lindemann, D., et al. (2016) · Viruses · doi:10.3390/v8110318 · Cited by 7
“A better understanding of the integration site selection process has recently emerged with the advent of next-generation sequencing methods to identify insertion sites, the resolution of the architecture of the prototype FV (PFV) integration machinery [14] and the identification of cellular cofactors involved in the p…”
MethodMolecular Modeling of Potential Dual Inhibitors of HIV Reverse Transcriptase and Integrase
Cabrera, A., Huerta, L., Chávez, D., & Medina‐Franco, J. L. (2018) · Computational Molecular Bioscience · doi:10.4236/cmb.2018.81001 · Cited by 7
Harshey, R. M. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch31 · Cited by 8
Identification and Optimization of a Novel HIV-1 Integrase Inhibitor
Adu‐Ampratwum, D., Pan, Y., Koneru, P. C., Antwi, J., Hoyte, A. C., Kessl, J. J., Griffin, P. R., Kvaratskhelia, M., Fuchs, J. R., & Larue, R. C. (2022) · ACS Omega · doi:10.1021/acsomega.1c06378 · Cited by 8
Brief Histories of Retroviral Integration Research and Associated International Conferences
Grandgenett, D. P., & Engelman, A. (2024) · Viruses · doi:10.3390/v16040604 · Cited by 8
“Peter Cherepanov presented the structure of the PFV intasome composed of IN bound to 19-mer pre-cleaved LTR substrate, which diffracted X-rays to 2.9 Å resolution [21].”
BackgroundInfluentialSelf-citationYu, S., Wang, P., Li, Y., Liu, Y., & Zhao, G. (2013) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2013.820792 · Cited by 7
“This breakthrough suggested an ‘induced fit mechanism’ theory, where lipophilic side chains of the inhibitor may fit into a hydrophobic pocket created by displacing the terminal conserved 3'-adenosine [30].”
BackgroundНикитина, П. А., Ткач, И. И., Knyazhanskaya, E. S., Gottikh, M., & Perevalov, V. P. (2016) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-016-1479-x · Cited by 7
Prototype foamy virus integrase is promiscuous for target choice
Mackler, R. M., Lopez, M. A., Osterhage, M. J., & Yoder, K. E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.031 · Cited by 7
“In contrast, PFV IN readily forms intasomes in vitro without a stabilizing co-factor [3,15].”
BackgroundStructural and Functional Aspects of Foamy Virus Protease-Reverse Transcriptase
Wöhrl, B. M. (2019) · Viruses · doi:10.3390/v11070598 · Cited by 7
Northrop, A. J., & Pomeroy, L. W. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002212 · Cited by 7
Nguyen, P. Q., Conesa, C., Rabut, E., Bragagnolo, G., Gouzerh, C., Fernández‐Tornero, C., Lesage, P., Reguera, J., & Acker, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101093 · Cited by 8
Prototype Foamy Virus Integrase Displays Unique Biochemical Activities among Retroviral Integrases
Rabe, A. J., Tan, Y. Y., Larue, R. C., & Yoder, K. E. (2021) · Biomolecules · doi:10.3390/biom11121910 · Cited by 6
“Retroviral intasomes may be assembled with a preprocessed vDNA and purified recombinant PFV IN [22].”
BackgroundMethodInfluentialMechanisms of Resistance to Antiviral Agents
Shafer, R. W., & Chou, S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch111 · Cited by 9
Musat, M., Nițulescu, G. M., Surleac, M. D., Tsatsakis, A. M., Spandidos, D. A., & Margina, D. M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10777 · Cited by 8
“raG2 is a 527 amino acids protein, essential for the proper function of raG1, comprised of a core region (1-387) and a c-terminal domain (388-527).”
Stability of HIV-1 integrase–ligand complexes: the role of coordinating bonds
Grigoriev, F. V., Golovacheva, A. Y., Romanov, A. N., Kondakova, O. A., Sulimov, A. V., Smolov, M., Gottikh, M., Sulimov, V. B., Bogolyubov, A. A., Kuznetsov, Y. V., et al. (2011) · Structural Chemistry · doi:10.1007/s11224-011-9855-3 · Cited by 7
Sun, Q., Biswas, A., Lyumkis, D., Levy, R., & Deng, N. (2024) · Viruses · doi:10.3390/v16010076 · Cited by 6
“The structure of the prototype foamy virus (PFV) intasome with bound INSTIs was determined in 2010 [6], and this complex has been accordingly used extensively for structure-based drug design efforts [4,7–9].”
MethodPoongavanam, V., Moorthy, N. S. H. N., & Kongsted, J. (2014) · RSC Advances · doi:10.1039/c4ra05728g · Cited by 7
Molecular Modeling of the Anti-HIV Activity Mechanism of Iodine-Containing Drugs Armenicum and FS-1
Yuldasheva, G. A., Argirova, R., & Ilin, A. I. (2023) · ACS Omega · doi:10.1021/acsomega.2c07720 · Cited by 6
Kalemera, M. D., Maher, A. K., Dominguez‐Villar, M., & Maertens, G. N. (2024) · Pharmaceuticals · doi:10.3390/ph17060730 · Cited by 7
“By binding this divalent cation, INSTIs displace the vDNA end from the integrase active site and, in doing so, deactivate the intasome [23,24].”
BackgroundRaltegravir flexibility and its impact on recognition by the HIV‐1 IN targets
Arora, R., de Beauchêne, I. C., Polański, J., Laine, É., & Tchertanov, L. (2013) · Journal of Molecular Recognition · doi:10.1002/jmr.2277 · Cited by 7
“The conformation of RAL determined by X-ray analysis of PFV IN DNA complex (Hare et al., 2010b) (PDB code: 3OYA) was optimized and docked to the vDNA (Models 3A and 3B) using GLIDE.”
BackgroundMethodInfluentialLevin, A., Benyamini, H., Hayouka, Z., Friedler, A., & Loyter, A. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07952.x · Cited by 6
Directed DNA Shuffling of Retrovirus and Retrotransposon Integrase Protein Domains
Qi, X., Vargas, E., Larsen, L. S. Z., Knapp, W., Hatfield, G. W., Lathrop, R. H., & Sandmeyer, S. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063957 · Cited by 7
“Alignment of Ty3 IN allowed identification of CCD boundaries consistent with those established for HIV-1 and PFV IN [13].”
BackgroundMethodErcan, S., & Pirinççioğlu, N. (2013) · Journal of Molecular Modeling · doi:10.1007/s00894-013-1943-4 · Cited by 6
“4 The superimposed structure of the full-length model with the previously reported model (left) [32] as well as with the foamy prototype (right) [27].”
BackgroundResultNi, X., Abdel‐Azeim, S., Laine, É., Arora, R., Osemwota, O., Marcelin, A., Cálvez, V., Mouscadet, J. F., & Tchertanov, L. (2012) · Advances in Virology · doi:10.1155/2012/548657 · Cited by 7
“Initial molecular geometries of ELV and RAL were taken from the X-ray structures 30YA (RAL) and 3L2U (ELV) of PFV IN·vDNA complexes [19, 20].”
BackgroundMethodInfluentialKhoury, L. E., Piquemal, J., Fermandjian, S., Maroun, R. G., Gresh, N., & Hobaika, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.001 · Cited by 8
Khoury, L. E., Célerse, F., Lagardère, L., Jolly, L.-H., Derat, É., Hobaika, Z., Maroun, R. G., Ren, P. Y., Bouaziz, S., Gresh, N., et al. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b01204 · Cited by 10
Ebrahimzadeh, E., Tabatabai, S. A., Vahabpour, R., Hajimahdi, Z., & Zarghi, A. (2019) · PubMed Central · doi:10.22037/ijpr.2019.112198.13597 · Cited by 11
Kotlar, R. M., Jones, N. D., Senavirathne, G., Gardner, A. M., Messer, R. K., Tan, Y. Y., Rabe, A. J., Fishel, R. A., & Yoder, K. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100550 · Cited by 6
“Structural studies of PFV intasomes revealed a tetramer of IN arranged with two catalytically active inner protomers and two structurally important outer protomers (2, 4, 5).”
BackgroundInfluentialGupta, M., & Madan, A. K. (2012) · Archiv der Pharmazie · doi:10.1002/ardp.201100316 · Cited by 6
Gresh, N., Hage, K. E., Goldwaser, E., de Courcy, B., Chaudret, R., Pérahia, D., Narth, C., Lagardère, L., Lipparini, F., & Piquemal, J. (2015) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-319-21626-3_1 · Cited by 7
The dynamics of interconverting D- and E-forms of the HIV-1 integrase N-terminal domain
Balasubramanian, S., Rajagopalan, M., & Ramaswamy, A. (2014) · European Biophysics Journal · doi:10.1007/s00249-014-0979-4 · Cited by 5
“…the HIV-2 INNTDCCD LEDGF/p75 complex (Hare et al. 2009b; Hare et al. 2009a), the HIV-1 INNTD-CCD tetramer (Wang et al. 2001) and the PFV tetramer (Hare et al. 2010), revealed the significant interactions stabilizing the IN dimer interface as: (1) charge–charge interactions between negatively…”
BackgroundInfluentialZarghi, A., Karimi, N., Vahabpour, R., & Hajimahdi, Z. (2021) · Medicinal Chemistry · doi:10.2174/1573406417666210929124944 · Cited by 6
Mahajan, P. S., Smith, S. J., Li, M., Craigie, R., Hughes, S. H., Zhao, X. Z., & Burke, T. R. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00525 · Cited by 7
Karthikeyan, D., Kumar, S., & Jayaprakash, N. S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131327 · Cited by 5
Retrovirus Integrase-DNA Structure Elucidates Concerted Integration Mechanisms
Grandgenett, D. P., & Korolev, S. (2010) · Viruses · doi:10.3390/v2051185 · Cited by 5
“In the 11 March 2010 issue of Nature, Peter Cherepanov and colleagues from the Imperial College, London, determined the crystal structure of the prototype foamy virus (PFV) integrase (IN) in complex with its viral DNA [1].”
BackgroundInfluentialHIV-1 Integration into Chromatin: New Insights and Future Perspectives
Lesbats, P., Lavigne, M., & Parissi, V. (2011) · Future Virology · doi:10.2217/fvl.11.84 · Cited by 7
Ammar, F. F., Hobaika, Z., Abdel‐Azeim, S., Zargarian, L., Maroun, R. G., & Fermandjian, S. (2015) · FEBS Open Bio · doi:10.1002/2211-5463.12025 · Cited by 7
Du, W., Zuo, K., Sun, X., Liu, W., Yan, X. H., Liang, L., Wan, H., Chen, F., & Hu, J. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.10.002 · Cited by 5
Krzemińska, A., & Świderek, K. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00276 · Cited by 5
Modulation of the functional interfaces between retroviral intasomes and the human nucleosome
Mauro, E., Lapaillerie, D., Tumiotto, C., Charlier, C., Martins, F. G., Sousa, S. F., Métifiot, M., Weigel, P., Yamatsugu, K., Kanai, M., et al. (2023) · mBio · doi:10.1128/mbio.01083-23 · Cited by 6
“first intasome that has been structurally characterized is the spumaretroviral proto type foamy virus (PFV) intasome, using X-ray crystallography, revealing a complex composed of four IN protomers (2).”
Method
Metadata
- Authors
- Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P.
- Affiliations
- Imperial College London (GB)
- The University of Queensland (AU)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Cherepanov, Peter
- Venue
- Nature
- Published
- 2010-01-31
- Volume
- 464
- Issue
- 7286
- Pages
- 232-236
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2837123
- OpenAlex
- W2025344323
- Cited by
- 678
- References
- 50
- Citations by year
- 2026: 14 · 2025: 10 · 2024: 15 · 2023: 21 · 2022: 19 · 2021: 31 · 2020: 29 · 2019: 38 · 2018: 33 · 2017: 31 · 2016: 43 · 2015: 53 · 2014: 49 · 2013: 68 · 2012: 79
- FWCI
- 60.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Diamond Light Source
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (R01AI070042, P30AI060354)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retroviral integrase, intasome, DNA strand transfer, HIV-1 integrase, integrase strand transfer inhibitors, raltegravir, elvitegravir, antiretroviral drug development, viral DNA integration, protein-DNA interactions
- MeSH terms
- DNA, Viral, Models, Molecular, Retroviridae, HIV-1, Protein Structure, Tertiary, Integrases, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.